Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 13, 2022

SELL
$57.56 - $82.54 $26,362 - $37,803
-458 Reduced 91.05%
45 $3,000
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $33,205 - $46,111
458 Added 1017.78%
503 $39,000
Q2 2021

Aug 13, 2021

BUY
$93.66 - $139.27 $4,214 - $6,267
45 New
45 $6,000
Q1 2021

Apr 14, 2021

SELL
$116.57 - $155.01 $5,245 - $6,975
-45 Closed
0 $0
Q3 2019

Nov 05, 2019

SELL
$90.37 - $122.49 $7,591 - $10,289
-84 Reduced 65.12%
45 $4,000
Q2 2019

Aug 09, 2019

BUY
$89.51 - $118.04 $7,518 - $9,915
84 Added 186.67%
129 $15,000
Q1 2019

Apr 08, 2019

BUY
$61.98 - $96.5 $2,789 - $4,342
45 New
45 $4,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.